Journal of Nutritional Sciences and Dietetics 2016. 2(5):.

Curcumin a novel agent targeting inflammatory pathways in obesity
Mohsen Sedighiyan, Mina Abdolahi, Niaz Mohammadzadeh Honarvar, Banafshe Hosseini, Kurosh Djafarian


The obesity considered a major public health concern that is increasing around the world. Obesity is characterized by chronic low-grade inflammation which contributes to metabolic dysfunction. Complelling evidence show potential protective and anti-inflammatory of Curcumin in obesity and metabolic disorder. Curcumin, the active metabolite of turmeric, interacts with white adipose tissue and suppress inflammatory responses through multiple biochemical and cellular mechanisms. Curcumin also can inhibit adipocyte differentiation, enhance fatty acid oxidation, improve lipid profile and has a role in increasing basal metabolic rate and weight control. Hence, curcumin can be considered as a therapeutic agent in modulating obesity and adverse health effects of that. Present review will focus on the all recent studies on potential anti-inflammatory roles of curcumin in obesity. This review is presented in several parts. The first explain inflammatory pathogenesis of obesity, the second the role of curcumin in inflammatory pathways, the third summarized the mechanisms of action of curcumin in adipose tissue and, finally, there is animal and human evidences of the potential beneficial effects of curcumin in obesity.


Curcumin, Obesity, inflammation, lipid, adiposity


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.